An organ system-based approach to prognosis in advanced melanoma

Frontiers in Bioscience - Elite

Volumn 4 E, Issue 8, 2012, Pages 2723-2733

  Holtan, Shernan G ^a   Mansfield, Aaron S ^a   Creedon, Douglas J ^a   Nevala, Wendy K ^b   Haluska, Paul ^a   Leontovich, Alexey A ^a   Markovic, Svetomir N ^a,b  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

Author keywords

B7H1 ; CD44; CD58; Galectin 9; Melanoma; Placenta; Systems biology; TIMP2; Tissue microarray; Tumor infiltrating lymphocytes

Indexed keywords

BIOLOGICAL MARKER; CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 1; CD3 ANTIGEN; CD56 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; ECALECTIN; GALECTIN 1; GALECTIN 3; GELATINASE A; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTEGRIN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3; MATRIX METALLOPROTEINASE INHIBITOR; NEUROPILIN 1; NEUROPILIN 2; PROSTAGLANDIN F; STROMAL CELL DERIVED FACTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; VASCULOTROPIN;

ADULT; ADVANCED CANCER; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; FEMALE; HUMAN; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; MALE; METASTATIC MELANOMA; OVERALL SURVIVAL; PROTEIN EXPRESSION; TISSUE MICROARRAY; TUMOR ASSOCIATED LEUKOCYTE;

EID: 84883581707     PISSN: 19450494     EISSN: 19450508     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Sekulic, A., P. Haluska, Jr., A. J. Miller, J. Genebriera De Lamo, S. Ejadi, J. S. Pulido, D. R. Salomao, E. C. Thorland, R. G. Vile, D. L. Swanson, B. A. Pockaj, S. D. Laman, M. R. Pittelkow & S. N. Markovic: Malignant melanoma in the 21st century: the emerging molecular landscape. Mayo Clin Proc, 83, 825-46 (2008)) (Pubitemid 351948695)
2. Mansfield, A. S., S. G. Holtan, T. E. Grotz, J. B. Allred, J. W. Jakub, L. A. Erickson & S. N. Markovic: Regional immunity in melanoma: immunosuppressive changes precede nodal metastasis. Mod Pathol (2010))
3. Holtan, S. G., D. J. Creedon, P. Haluska & S. N. Markovic: Cancer and pregnancy: parallels in growth, invasion, and immune modulation and implications for cancer therapeutic agents. Mayo Clin Proc, 84, 985-1000 (2009))
4. Soundararajan, R. & A. J. Rao: Trophoblast 'pseudotumorigenesis': significance and contributory factors. Reprod Biol Endocrinol, 2, 15 (2004))
5. Ferretti, C., L. Bruni, V. Dangles-Marie, A. P. Pecking & D. Bellet: Molecular circuits shared by placental and cancer cells, and their implications in the proliferative, invasive and migratory capacities of trophoblasts. Hum Reprod Update, 13, 121-41 (2007)) (Pubitemid 46323191)
6. Petty, A. P., K. L. Garman, V. D. Winn, C. M. Spidel & J. S. Lindsey: Overexpression of carcinoma and embryonic cytotrophoblast cell-specific Mig-7 induces invasion and vessel-like structure formation. Am J Pathol, 170, 1763-80 (2007)) (Pubitemid 47339319)
7. Holtan, S. G. & D. J. Creedon: Mother knows best: Lessons from fetomaternal tolerance applied to cancer immunity. Front Biosci (Schol Ed), 3, 1533-1540 (2011))
8. Bogunovic, D., D. W. O'Neill, I. Belitskaya-Levy, V. Vacic, Y. L. Yu, S. Adams, F. Darvishian, R. Berman, R. Shapiro, A. C. Pavlick, S. Lonardi, J. Zavadil, I. Osman & N. Bhardwaj: Immune profile and mitotic index of metastatic melanoma lesions enhance clinical staging in predicting patient survival. Proc Natl Acad Sci, 106, 20429-34 (2009))
9. Harlin, H., Y. Meng, A. C. Peterson, Y. Zha, M. Tretiakova, C. Slingluff, M. McKee & T. F. Gajewski: Chemokine expression in melanoma metastases associated with CD8+ T-cell recruitment. Cancer Res, 69, 3077-85 (2009))
10. Altomonte, M., A. Gloghini, G. Bertola, A. Gasparollo, A. Carbone, S. Ferrone & M. Maio: Differential Expression of Cell-Adhesion Molecules Cd54/Cd11a and Cd58/Cd2 by Human-Melanoma Cells and Functional-Role in Their Interaction with Cytotoxic-Cells. Cancer Research, 53, 3343-3348 (1993)) (Pubitemid 23223307)
11. Talbi, S., A. E. Hamilton, K. C. Vo, S. Tulac, M. T. Overgaard, C. Dosiou, N. Le Shay, C. N. Nezhat, R. Kempson, B. A. Lessey, N. R. Nayak & L. C. Giudice: Molecular phenotyping of human endometrium distinguishes menstrual cycle phases and underlying biological processes in normo-ovulatory women. Endocrinology, 147, 1097-121 (2006)) (Pubitemid 43244341)
12. Hefler, L., C. Kainz, H. Zeisler, G. Heinze, C. Schatten, P. Husslein, S. Leodolter & C. Tempfer: Serum levels of leukocyte functional antigen-3 in pregnancy and preeclampsia. Acta Obstet Gynecol Scand, 78, 580-5 (1999)) (Pubitemid 29322467)
13. Zhu, C., A. C. Anderson, A. Schubart, H. Xiong, J. Imitola, S. J. Khoury, X. X. Zheng, T. B. Strom & V. K. Kuchroo: The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat Immunol, 6, 1245-52 (2005)) (Pubitemid 43045636)
14. Popovici, R. M., M. S. Krause, A. Germeyer, T. Strowitzki & M. von Wolff: Galectin-9: a new endometrial epithelial marker for the mid- and late-secretory and decidual phases in humans. J Clin Endocrinol Metab, 90, 6170-6 (2005))
15. Su, E. W., S. Bi & L. P. Kane: Galectin-9 regulates T helper cell function independently of Tim-3. Glycobiology, 21, 1258-65 (2011))
16. Nobumoto, A., K. Nagahara, S. Oomizu, S. Katoh, N. Nishi, K. Takeshita, T. Niki, A. Tominaga, A. Yamauchi & M. Hirashima: Galectin-9 suppresses tumor metastasis by blocking adhesion to endothelium and extracellular matrices. Glycobiology, 18, 735-44 (2008))
17. Kageshita, T., Y. Kashio, A. Yamauchi, M. Seki, M. J. Abedin, N. Nishi, H. Shoji, T. Nakamura, T. Ono & M. Hirashima: Possible role of galectin-9 in cell aggregation and apoptosis of human melanoma cell lines and its clinical significance. Int J Cancer, 99, 809-16 (2002)) (Pubitemid 34575697)
18. Wiersma, V. R., M. de Bruyn, W. Helfrich & E. Bremer: Therapeutic potential of Galectin-9 in human disease. Med Res Rev (in press))
19. Choi, C. H., C. R. Roh, T. J. Kim, Y. L. Choi, J. W. Lee, B. G. Kim, J. H. Lee & D. S. Bae: Expression of CD44 adhesion molecules on human placentae. Eur J Obstet Gynecol Reprod Biol, 128, 243-7 (2006)) (Pubitemid 44311344)
20. Sviatoha, V., E. Tani, R. Kleina, M. Sperga & L. Skoog: Immunohistochemical analysis of the S100A1, S100B, CD44 and Bcl-2 antigens and the rate of cell proliferation assessed by Ki-67 antibody in benign and malignant melanocytic tumours. Melanoma Res, 20, 118-25 (2010))
21. Dietrich, A., E. Tanczos, W. Vanscheidt, E. Schopf & J. C. Simon: High CD44 surface expression on primary tumours of malignant melanoma correlates with increased metastatic risk and reduced survival. Eur J Cancer, 33, 926-30 (1997)) (Pubitemid 27287047)
22. Brandsma, D., J. C. Reijneveld, M. J. Taphoorn, H. C. de Boer, M. F. Gebbink, L. H. Ulfman, J. J. Zwaginga & E. E. Voest: Vascular cell adhesion molecule-1 is a key adhesion molecule in melanoma cell adhesion to the leptomeninges. Lab Invest, 82, 1493-502 (2002)) (Pubitemid 35332908)
23. Schlosser, W., F. Gansauge, S. Schlosser, S. Gansauge & H. G. Beger: Low serum levels of CD44, CD44v6, and neopterin indicate immune dysfunction in chronic pancreatitis. Pancreas, 23, 335-40 (2001)) (Pubitemid 32983289)
24. Yasasever, V., F. Tas, D. Duranyildiz, H. Camlica, S. Kurul & N. Dalay: Serum levels of the soluble adhesion molecules in patients with malignant melanoma. Pathol Oncol Res, 6, 42-5 (2000)) (Pubitemid 30262778)
25. Ulbrich, S. E., S. U. Meyer, K. Zitta, S. Hiendleder, F. Sinowatz, S. Bauersachs, M. Buttner, T. Frohlich, G. J. Arnold, H. D. Reichenbach, E. Wolf & H. H. Meyer: Bovine endometrial metallopeptidases MMP14 and MMP2 and the metallopeptidase inhibitor TIMP2 participate in maternal preparation of pregnancy. Mol Cell Endocrinol, 332, 48-57 (2011))
26. Polette, M., B. Nawrocki, A. Pintiaux, C. Massenat, E. Maquoi, L. Volders, J. P. Schaaps, P. Birembaut & J. M. Foidart: Expression of gelatinases A and B and their tissue inhibitors by cells of early and term human placenta and gestational endometrium. Lab Invest, 71, 838-46 (1994))
27. Seo, D. W., H. Li, L. Guedez, P. T. Wingfield, T. Diaz, R. Salloum, B. Y. Wei & W. G. Stetler-Stevenson: TIMP-2 mediated inhibition of angiogenesis: an MMP-independent mechanism. Cell, 114, 171-80 (2003)) (Pubitemid 36936911)
28. Chae, J. K., I. Kim, S. T. Lim, M. J. Chung, W. H. Kim, H. G. Kim, J. K. Ko & G. Y. Koh: Coadministration of angiopoietin-1 and vascular endothelial growth factor enhances collateral vascularization. Arterioscler Thromb Vasc Biol, 20, 2573-8 (2000))